Skip to main content
GINWA ENTERPRISE (GROUP) INC. logo

GINWA ENTERPRISE (GROUP) INC. — Investor Relations & Filings

Ticker · 600080 ISIN · CNE000000QQ8 Shanghai Stock Exchange Manufacturing
Filings indexed 1,715 across all filing types
Latest filing 2024-04-26 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600080

About GINWA ENTERPRISE (GROUP) INC.

http://www.ginwa.com.cn/

Ginwa Enterprise (Group) Inc. operates as a diversified conglomerate focused on the research, development, manufacturing, and distribution of medical products. The company's portfolio includes traditional Chinese medicines, chemical drugs, and biological preparations targeting therapeutic areas such as cardiovascular health, anti-infectives, and digestive disorders. In addition to its medical operations, the group is involved in high-tech development, real estate, and strategic investment activities. The organization prioritizes technological innovation and adheres to rigorous quality control standards across its production facilities. It serves a broad market base, focusing on the modernization of traditional medicinal practices and the integration of advanced biotechnology into its product offerings.

Recent filings

Filing Released Lang Actions
金花企业(集团)股份有限公司关于使用暂时闲置资金购买理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the company Jinhua Enterprise (Group) Co., Ltd. regarding the use of temporarily idle funds to purchase financial products. It details the board meeting approval, investment purpose, amount, risk control measures, and impact on the company. The document is a formal public announcement about a financing or capital management activity, specifically about using idle funds to invest in financial products. It does not contain financial statements or detailed financial results, nor is it a report or transcript. It is not a regulatory certification or a report publication announcement. The content fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities related to capital usage and investment of idle funds.
2024-04-26 Chinese
关于金花企业(集团)股份有限公司2023年度营业收入扣除情况的专项说明
Regulatory Filings
2024-04-26 Chinese
金花企业(集团)股份有限公司董事会关于独立董事独立性自查情况的专项意见
Governance Information Classification · 95% confidence The document is a statement from the board of directors regarding the independence of the company's independent directors. It references regulatory requirements from the China Securities Regulatory Commission and the Shanghai Stock Exchange, confirming compliance with independence rules. The document is a formal opinion or announcement about governance compliance rather than a full report, financial statement, or meeting material. It does not contain financial data, voting results, or executive changes. This fits best under Governance Information (CGR), which covers reports detailing internal rules, board structure, and governance practices.
2024-04-26 Chinese
金花企业(集团)股份有限公司2023年年度报告
Annual Report Classification · 100% confidence The document is titled '2023 年年度报告' which translates to '2023 Annual Report'. It contains detailed financial data, management discussion and analysis, company overview, financial statements, audit opinions, and other comprehensive information typical of a full annual report. The document length is substantial (15,000 characters), and it includes audited financial results, risk disclosures, business descriptions, and governance information. There is no indication that this is merely an announcement or a summary; rather, it is the full annual report itself. Therefore, the appropriate classification is 'Annual Report' with code '10-K'. FY 2023
2024-04-26 Chinese
金花企业(集团)股份有限公司2023年度审计报告
Regulatory Filings
2024-04-26 Chinese
金花企业(集团)股份有限公司第十届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 9th meeting of the 10th Board of Directors of Jinhua Enterprise (Group) Co., Ltd. It includes approvals of various reports such as the 2023 Annual Report, internal control evaluation report, financial statements, profit distribution plan, and other governance and audit-related matters. The document repeatedly states that these reports and proposals will be submitted to the shareholders' meeting for approval and that the full reports are disclosed elsewhere (e.g., Shanghai Stock Exchange website). The document itself does not contain the full annual report or detailed financial statements but is a formal announcement of board meeting decisions and approvals. This fits the category of Board/Management Information (MANG), which covers announcements of board decisions and management matters. The document length is under 5,000 characters and it references other documents for full details, so it is not the full Annual Report (10-K) or Audit Report (AR). Therefore, the correct classification is MANG with high confidence.
2024-04-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.